American Invest Hub
  • Politics
  • Investing
  • Business
  • Latest News

American Invest Hub

  • Politics
  • Investing
  • Business
  • Latest News
Investing

Placement to Support Next Phases of Grandis Project

by admin July 25, 2024
July 25, 2024
Placement to Support Next Phases of Grandis Project

Elixir Energy Limited (Elixir or the Company) is pleased to announce that it has received binding commitments for a placement of new shares in the Company (Placement), on the following terms:

1. Placement to raise $6.25 million (before costs) through the issue of 62.5 million new shares to institutional and sophisticated investors at a price of 10 cents per share (a 13% discount to the last close and a 12.7% discount to the 5 day VWAP).

2. Placement participants will receive one (1) one of Elixir’s currently listed options (EXROBs) for every four (4) Placement Shares issued. These already listed EXROB Options have an exercise price of 12 cents and a term expiring on 17 October 2026.

HIGHLIGHTS

Over-subsribed share placement of $6.25 million to institutional and sophisticated investorsFunds to be used to support the next phases of the Grandis Project

The capital raising was strongly supported, with demand in excess of the placement size, and introduced a number of new institutional investors to the Company’s register.

The new capital raised will be deployed in the next phases of the Grandis Project – to deal with potential contingencies that might arise from the imminent multiple stage stimulation and flow testing program at the Company’s Daydream-2 well; and, position the Company for the next phases of Project Grandis – including ordering long lead items for the next well and improving the negotiating position for potential farm-out negotiations post the flow testing phase.

The 62.5 million Placement Shares will be issued under listing rule 7.1 A and the 18,750,000 Listed Options will be issued under listing rule 7.1.

The new shares are anticipated to be issued on Wednesday, 31 July 2024.

Taylor Collison Limited and Originate Capital Pty Ltd acted as Joint Lead Managers to the Placement.

Elixir’s Managing Director, Mr. Neil Young, said: “We are pleased to receive this financial support from existing and new investors to fund the final phases of the Daydream-2 program and take forward Project Grandis into its next phases. Equipment is mobilizing to the well lease and the commencement of work is now imminent.”

Click here for the full ASX Release

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Copper Price Update: Q2 2024 in Review
next post
Adisyn Ltd (ASX: AI1) – Trading Halt

Related Posts

Here’s why T-Mobile stock price keeps beating AT&T...

March 13, 2025

Cardiol Therapeutics

February 7, 2024

Marvel Discovery Acquires Strategic Ground In Elliot Lake,...

May 24, 2024

XRP price prediction: why it could crash despite...

March 30, 2025

Walmart stock price is firing on all cylinders:...

November 27, 2024

USD/MXN forecast ahead of Fed and Banxico rate...

December 15, 2024

9 Arrests Made in Canada’s Largest Gold Heist

April 18, 2024

Top S&P 500 Index stocks to watch: PANW,...

May 18, 2025

Shiba Inu price analysis: Here’s why SHIB is...

December 5, 2024

Tesla Shares Jump on Full Self-Driving Milestone in...

May 1, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • Trump wants Apple to shift iPhone production from India to the US: here’s what it means

      May 18, 2025
    • Inflation outlook in 2025: what April’s soft data isn’t telling you

      May 18, 2025
    • Rich List 2025: UK billionaires decline for first time in years amid market turmoil

      May 18, 2025
    • Novo Nordisk CEO to step down as obesity drug competition intensifies

      May 18, 2025
    • Argentina’s black market for dollar falters as President Milei dismantles currency controls

      May 18, 2025

    Categories

    • Business (2,891)
    • Investing (2,402)
    • Latest News (1,990)
    • Politics (1,530)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: americaninvesthub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 americaninvesthub.com | All Rights Reserved